Liver | Brain | |||
---|---|---|---|---|
IC50 | Slope | IC50 | Slope | |
nm | nm | |||
Ifenprodil | 2.4 ± 0.7 | 0.95 ± 0.15 | 1.7 ± 0.4 | 0.85 ± 0.05 |
Haloperidol | 6.8 ± 2.8 | 0.64 ± 0.082-a | 23 ± 6 | 0.64 ± 0.042-a |
Ditolylguanidine | 122 ± 33 | 0.55 ± 0.052-b | 36 ± 11 | 0.70 ± 0.092-b |
Trifluoperazine | 11 ± 2 | 1.10 ± 0.13 | 13 ± 1 | 0.93 ± 0.06 |
(−) -Emopamil | 28 ± 15 | 1.00 ± 0.12 | 34 ± 17 | 0.81 ± 0.09 |
Microsomes from guinea pig liver and brain were prepared as described in Experimental Procedures. Saturation analysis revealedB max values of the liver and brain [3H] ifenprodil binding sites of 42 ± 3 and 7.6 ± 0.2 pmol/mg of microsomal protein (n = 3) (K d = 2.5 ± 0.8 and 1.9 ± 0.6 nm, respectively; (n = 3).
Data shown are mean ± standard deviation (n = 3).
Biphasic fitting of the data (see Fig. 2) gave the following IC50 values.
↵2-a Haloperidol: Liver IC50 (high) = 2.9 ± 1.6 nm, IC50 (low) = 141 ± 67 nm(30 ± 6% of sites); brain IC50 (high) = 11 ± 8 nm, IC50 (low) = 1,720 ± 1,060 nm(16 ± 2% of sites).
↵2-b Ditolylguanidine: Liver IC50 (high) = 22 ± 8 nm, IC50 (low) = 4,500 ± 1,400 nm(34 ± 6% of sites); brain IC50 (high) = 27 ± 4 nm, IC50 (low) = 24,000 ± 8,000 nm (12 ± 2% of sites).